Radiopharma: an international symposium at Nantes in 2021
After receiving 2,225 submitted abstracts – a new all-time record – also in terms of participation at the EANM congress... View Article
Affilogic is financing a proof of concept thanks to the Boost4Health programme
Affilogic,a member of Atlanpole Biotherapies, has received a € 5000 voucher as part of the Boost4Health programme. This support has... View Article
ArronaxPlus [video]
ArronaxPlus presentation in video !
Lemer Pax: Posijet®, the history of an exemplary partnership
The latest version of Posijet®, a mobile unit for the preparation and injection of high-energy radiopharmaceuticals, has become the compact... View Article
Atlab Pharma & Telix Pharmaceuticals: agreement for prostate cancer
From Australia to France Atlab Pharma (Nantes, FRANCE) and Telix Pharmaceuticals (Melbourne, AUSTRALIA) conclude a Therapeutic Product Development Agreement for Prostate... View Article
ARRONAX PLUS: NEW TOOLS TO ENRICH THE NUCLEAR ARSENAL AGAINST CANCER
The objective in nuclear medicine (imaging and therapy) is to build up both a world-class research group and eventually... View Article
Atlanpole Biotherapies joins CEBR Board
The Council of European BioRegions (CEBR) is a network of biotechnology support professionals that support their local biocommunity through direct services including... View Article
A New member: Gammeo
Gammeo enables the monitoring of all property issues related to a health facility through a simple and intuitive web interface.... View Article
The attraction of CESTI IHU has been the establishment of a professorial position specifically for Pierre-Antoine Gourraud
Professor Pierre-Antoine Gourraud, a recognized specialist in the fields of immunology, genetics and bioinformatics, leaves his position of Associate Professor... View Article
FIRM project was funded at the level of 15 million euros
FIRM project is aimed at the development of an industrial sector producing innovative radioisotopes for medical use. Coordinated by the... View Article